Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Centrosomal protein of 44 kDa (CEP44) is a conserved, non-enzymatic structural protein localized to the proximal end and lumen of centrioles within the centrosome[1][2][3]. CEP44 is essential for centrosome cohesion (holding duplicated centrosomes together until their separation in mitosis), ensuring accurate centriole duplication, and enabling the centriole-to-centrosome conversion required for the formation of mature centrosomes capable of nucleating microtubules[1][2][3]. CEP44 closely interacts with structural proteins such as rootletin and POC1B, stabilizing these components for proper centrosome function[1][3]. Loss of CEP44 disrupts centrosome cohesion, centriole structure, and mitotic spindle pole formation, leading to defects in cell division[1][2][3]. Expression of CEP44 is downregulated in breast carcinoma, correlating with poorer clinical outcomes, which suggests a potential (though as yet non-therapeutic) role in tumor suppression mechanisms[2]. There are no known drugs that directly target CEP44, and it is not currently classified as a therapeutic target.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Centrosomal protein of 44 kDa (CEP44).